This after-action review (AAR) investigates the use of evidence in Sweden’s advice-making process for distance learning during the period November 2020 to April 2021 (the

The public health advice-making process on schools in Sweden during the COVID-19 pandemic from November 2020 to April 2021 has undergone an After-Action Review (AAR),

This document presents the core protocol for ECDC studies of CVE and IVE against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection, respectively, at primary care level.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24-30 September 2023 and includes updates on severe floods, Severe floods, Avian

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 September 2023 and includes updates on Nipah virus disease, severe floods,

Statement from ECDC Director Andrea Ammon on the current state of influenza, RSV and COVID-19 with the arrival of autumn and winter.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 September 2023 and includes updates on COVID-19, diphtheria, West Nile virus,

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 August – 2 September and includes updates on Legionnaires’ disease, dengue

Today ECDC is providing an update on the current status of COVID-19 transmission in the European Union and European Economic Area (EU/EEA), the emergence of

In recent weeks, signals of SARS-CoV-2 transmission have increased from previously very low levels in the EU/EEA.